Fulgent Genetics, Inc. (NAS: FLGT) Stock Analysis & Fundamentals | ScreenerHero

Create free account

FLGTFulgent Genetics, Inc.

NAS · US · Healthcare · Diagnostics & Research · fulgentgenetics.com

20.55USD-2.19%Mkt Cap: 583.63M $P/E: —1d ago

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular…

Industry Peers

Diagnostics & Research

Thermo Fisher Scientific Inc.

$201.86BUSDP/E 29.8

Danaher Corporation

$145.10BUSDP/E 39.7

$45.85BUSDP/E 44.2

IDEXX Laboratories, Inc.

$45.44BUSDP/E 42.4

Agilent Technologies, Inc.

$38.44BUSDP/E 27.3

Waters Corporation

$37.13BUSDP/E 48.1

IQVIA Holdings Inc.

$35.13BUSDP/E 26.2

$28.78BUSDP/E 34.6

Mettler-Toledo International Inc.

$26.98BUSDP/E 31.4

Quest Diagnostics Incorporated

$23.18BUSDP/E 23.1

Labcorp Holdings Inc.

$23.12BUSDP/E 25.0

Guardant Health, Inc.

Medpace Holdings, Inc.

$15.36BUSDP/E 33.9

Eurofins Scientific SE

$13.06BUSDP/E 27.3

$12.46BUSDP/E 53.7

Charles River Laboratories International, Inc.

bioMérieux S.A.

$9.26BUSDP/E 21.6

BillionToOne, Inc.

$5.90BUSDP/E 237.4

Twist Bioscience Corporation

Sotera Health Company

$5.21BUSDP/E 44.6

$4.73BUSDP/E 54.8

DiaSorin S.p.A.

$3.75BUSDP/E 26.5

Adaptive Biotechnologies Corporation

NeoGenomics, Inc.

GeneDx Holdings Corp.

Vimian Group AB (publ)

$1.64BUSDP/E 41.7

Personalis, Inc.

Diagnostyka S.A.

$1.48BUSDP/E 22.4

Clínica Baviera, S.A.

$1.02BUSDP/E 21.4

OPKO Health, Inc.

Castle Biosciences, Inc.

$616.40MUSDP/E 40.2

Myriad Genetics, Inc.

$293.12MUSDP/E 2.9

Spectral Medical Inc.

Insight Molecular Diagnostics Inc.

Scope Fluidics S.A.

Eurofins-Cerep SA

$89.37MUSDP/E 17.2

Pangaea Oncology, S.A.

Abingdon Health Plc

Immunovia AB (publ)

Proteome Sciences plc

ENDRA Life Sciences Inc.

Oxford BioDynamics Plc

Avricore Health Inc.

bioAffinity Technologies, Inc.

Leveljump Healthcare Corp.

Prostatype Genomics AB (publ)

Telo Genomics Corp.

ProPhase Labs, Inc.

Many Bright Ideas Technologies Inc.

$314.2KUSDP/E Infinity

T2 Biosystems, Inc.

Indicators:|

Key Statistics

Company

Market Cap583.63M $

Enterprise Value311.84M $

Revenue (TTM)320.35M $

Gross Profit130.88M $

Net Income (TTM)-60.51M $

Revenue/Share10.40 USD

Last Price20.55 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees1.3K

CountryUS

SectorHealthcare

IndustryDiagnostics & Research

ISINUS3596641098

Valuation

P/E (Trailing)—

P/E (Forward)-13.45

PEG—

EV/EBITDA-4.04

EV/Revenue0.97

P/S1.82

P/B0.56

EPS (TTM)-2.40

EPS (Forward)-1.53

52W Range

13.4640% of range31.04

52W High31.04 USD

52W Low13.46 USD

Profitability

Gross Margin40.56%

Oper. Margin-45.01%

EBITDA Margin-24.10%

Profit Margin-18.75%

ROE-5.44%

ROA-4.99%

Growth

Revenue Growth-3.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-101.64M $

CapEx (TTM)22.57M $

FCF Margin-33.07%

FCF Yield-18.15%

Net Debt-266.13M $

Net Debt/EBITDA3.45

Balance Sheet

Debt/Equity0.01

Current Ratio5.32

Quick Ratio3.91

Book Value/Sh36.39 USD

Cash/Share9.729 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)18.50 USD

Upside (mean)-10.0%

Target Range15.00 USD – 22.00 USD

$15.00-10.0% to mean$22.00

# Analysts2

Ownership

Shares Out.28.40M

Float17.56M

Insiders36.66%

Institutions63.41%

Short Interest

Short Ratio6.9d

Short % Float14.58%

Short % Out.9.25%

Shares Short2.63M

Short (prev mo.)2.80M

Technical

SMA 5018.25 (+12.6%)

SMA 20021.55 (-4.7%)

Beta0.89

S&P 52W Chg20.25%

Avg Vol (30d)305.01K

Avg Vol (10d)243.65K

Technical Indicators

RSI (14)59.9

MACD0.7283

MACD Signal0.7834

MACD Hist.-0.0551

BB Upper22.36 USD

BB Middle19.86 USD

BB Lower17.36 USD

BB Width25.18%

ATR (14)0.6980 USD

Vol Ratio (20d)0.79x